B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Galactosamine

300 PubMed studies analyzed ยท Evidence Score: 38

Research Domains

Galactosamine has been studied across 17 research domains including ๐Ÿซ Liver & Detox, ๐Ÿ”ฅ Metabolic, ๐Ÿ”ฌ Oncology, ๐Ÿ”ฌ Inflammation, ๐Ÿ›ก๏ธ Immunity. The primary research focus is ๐Ÿซ Liver & Detox with 68% of studies addressing this area.

Loading evidence profile...

This evidence profile for Galactosamine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.